Active
Company Information for ZENTIVA PHARMA UK LIMITED
12 NEW FETTER LANE, LONDON, EC4A 1JP,
|
Company Registration Number
02158996
Private Limited Company
Active |
Company Name | ||||
---|---|---|---|---|
ZENTIVA PHARMA UK LIMITED | ||||
Legal Registered Office | ||||
12 NEW FETTER LANE LONDON EC4A 1JP Other companies in GU1 | ||||
Previous Names | ||||
|
Company Number | 02158996 | |
---|---|---|
Company ID Number | 02158996 | |
Date formed | 1987-08-28 | |
Country | ENGLAND | |
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Active | |
Lastest accounts | 31/12/2022 | |
Account next due | 30/09/2024 | |
Latest return | 31/12/2015 | |
Return next due | 28/01/2017 | |
Type of accounts | FULL |
Last Datalog update: | 2024-02-05 05:57:12 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Officer | Role | Date Appointed |
---|---|---|
FRANCOIS-XAVIER DUHALDE |
||
HUGO RUPERT ALEXANDER FRY |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
TARJA JOHANNA STENVALL |
Director | ||
ANDREW MICHAEL JAMES PROSSER |
Director | ||
STEPHEN PHILIP OLDFIELD |
Director | ||
MICHAEL JAMES MCCLELLAN |
Director | ||
MICHAEL JAMES MCCLELLAN |
Company Secretary | ||
NIGEL STANLEY BROOKSBY |
Director | ||
HELEN ROBERTS |
Company Secretary | ||
BLAKE ALEXANDER RICHARD DARK |
Director | ||
GUILLAUME ADRIEN DE FORCEVILLE |
Director | ||
ETIENNE MARIE CHARLES ROBERT JACOB |
Director | ||
ERIC KING |
Director | ||
THIERRY VERNIER |
Director | ||
CHRISTOPHE GOURLET |
Director | ||
OLIVIER ALAIN THIBERGE |
Director | ||
GORDON DENNIS THUILLIEZ |
Company Secretary | ||
GORDON DENNIS THUILLIEZ |
Director | ||
SUSAN MARY MAUD BEWS |
Director | ||
ANTHONY WARNOCK-SMITH |
Company Secretary | ||
ANTHONY WARNOCK-SMITH |
Director | ||
PAUL WODDIS |
Director |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
LOREX SYNTHELABO LIMITED | Director | 2016-04-01 | CURRENT | 1981-07-02 | Dissolved 2016-08-23 | |
ROUSSEL LABORATORIES LIMITED | Director | 2016-04-01 | CURRENT | 1938-01-21 | Dissolved 2017-08-01 | |
BUSINESS EAST SCIENCE AND TECHNOLOGY PARK LIMITED | Director | 2016-04-01 | CURRENT | 2013-07-08 | Dissolved 2017-08-01 | |
GENZYME THERAPEUTICS LIMITED | Director | 2016-04-01 | CURRENT | 2001-11-05 | Active | |
FISONS LIMITED | Director | 2016-04-01 | CURRENT | 1895-07-23 | Active | |
AVENTIS PHARMA HOLDINGS LIMITED | Director | 2016-04-01 | CURRENT | 1999-09-03 | Active | |
SANOFI-SYNTHELABO LIMITED | Director | 2016-04-01 | CURRENT | 1990-09-03 | Active - Proposal to Strike off | |
SANOFI PASTEUR HOLDING LIMITED | Director | 2016-04-01 | CURRENT | 1993-10-19 | Active - Proposal to Strike off | |
RPR (US) LIMITED | Director | 2016-04-01 | CURRENT | 1996-05-24 | Active | |
SANOFI-AVENTIS UK HOLDINGS LIMITED | Director | 2016-04-01 | CURRENT | 1996-05-24 | Active | |
CHATTEM (U.K.) LIMITED | Director | 2016-04-01 | CURRENT | 1980-01-09 | Active - Proposal to Strike off | |
AVENTIS PHARMA LIMITED | Director | 2016-04-01 | CURRENT | 1980-12-18 | Active | |
MAY & BAKER LIMITED | Director | 2016-04-01 | CURRENT | 1989-12-07 | Active | |
ACAMBIS RESEARCH LIMITED | Director | 2016-04-01 | CURRENT | 1992-12-18 | Active - Proposal to Strike off | |
HOECHST MARION ROUSSEL LIMITED | Director | 2016-04-01 | CURRENT | 1994-06-29 | Active - Proposal to Strike off | |
RHONE-POULENC RORER LIMITED | Director | 2016-04-01 | CURRENT | 1986-02-13 | Active | |
SANOFI-SYNTHELABO UK LIMITED | Director | 2016-04-01 | CURRENT | 1961-05-16 | Active | |
ROUSSEL LABORATORIES LIMITED | Director | 2017-01-01 | CURRENT | 1938-01-21 | Dissolved 2017-08-01 | |
BUSINESS EAST SCIENCE AND TECHNOLOGY PARK LIMITED | Director | 2017-01-01 | CURRENT | 2013-07-08 | Dissolved 2017-08-01 | |
AVENTIS PHARMA HOLDINGS LIMITED | Director | 2017-01-01 | CURRENT | 1999-09-03 | Active | |
SANOFI-SYNTHELABO LIMITED | Director | 2017-01-01 | CURRENT | 1990-09-03 | Active - Proposal to Strike off | |
SANOFI PASTEUR HOLDING LIMITED | Director | 2017-01-01 | CURRENT | 1993-10-19 | Active - Proposal to Strike off | |
RPR (US) LIMITED | Director | 2017-01-01 | CURRENT | 1996-05-24 | Active | |
SANOFI-AVENTIS UK HOLDINGS LIMITED | Director | 2017-01-01 | CURRENT | 1996-05-24 | Active | |
CHATTEM (U.K.) LIMITED | Director | 2017-01-01 | CURRENT | 1980-01-09 | Active - Proposal to Strike off | |
AVENTIS PHARMA LIMITED | Director | 2017-01-01 | CURRENT | 1980-12-18 | Active | |
MAY & BAKER LIMITED | Director | 2017-01-01 | CURRENT | 1989-12-07 | Active | |
ACAMBIS RESEARCH LIMITED | Director | 2017-01-01 | CURRENT | 1992-12-18 | Active - Proposal to Strike off | |
HOECHST MARION ROUSSEL LIMITED | Director | 2017-01-01 | CURRENT | 1994-06-29 | Active - Proposal to Strike off | |
RHONE-POULENC RORER LIMITED | Director | 2017-01-01 | CURRENT | 1986-02-13 | Active | |
SANOFI-SYNTHELABO UK LIMITED | Director | 2017-01-01 | CURRENT | 1961-05-16 | Active |
Date | Document Type | Document Description |
---|---|---|
CONFIRMATION STATEMENT MADE ON 31/12/23, WITH NO UPDATES | ||
FULL ACCOUNTS MADE UP TO 31/12/22 | ||
APPOINTMENT TERMINATED, DIRECTOR LUKE INGMIRE HART | ||
TM01 | APPOINTMENT TERMINATED, DIRECTOR LUKE INGMIRE HART | |
CONFIRMATION STATEMENT MADE ON 31/12/22, WITH NO UPDATES | ||
CS01 | CONFIRMATION STATEMENT MADE ON 31/12/22, WITH NO UPDATES | |
DIRECTOR APPOINTED SOPHIE QUIN | ||
AP01 | DIRECTOR APPOINTED SOPHIE QUIN | |
AA | FULL ACCOUNTS MADE UP TO 31/12/21 | |
CONFIRMATION STATEMENT MADE ON 31/12/21, WITH UPDATES | ||
CS01 | CONFIRMATION STATEMENT MADE ON 31/12/21, WITH UPDATES | |
AA | FULL ACCOUNTS MADE UP TO 31/12/20 | |
SH01 | 19/01/21 STATEMENT OF CAPITAL GBP 16928199 | |
SH01 | 06/01/21 STATEMENT OF CAPITAL GBP 16928199 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/19 | |
CS01 | CONFIRMATION STATEMENT MADE ON 31/12/20, WITH NO UPDATES | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR JANE HILL | |
AP01 | DIRECTOR APPOINTED MR ANTHONY DANIEL KNIGHT | |
CH01 | Director's details changed for Mr Luke Ingmire Hart on 2020-09-09 | |
AD02 | Register inspection address changed from Office 136-152 Austen House Station View Units a-J Guildford Surrey GU1 4AR to Austen House Station View Guildford GU1 4AR | |
CS01 | CONFIRMATION STATEMENT MADE ON 31/12/19, WITH NO UPDATES | |
AA | SMALL COMPANY ACCOUNTS MADE UP TO 31/12/18 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR MANISH KHANDELWAL | |
AP01 | DIRECTOR APPOINTED MR LUKE INGMIRE HART | |
AD01 | REGISTERED OFFICE CHANGED ON 24/06/19 FROM One Onslow Street Guildford Surrey GU1 4YS | |
MR01 | REGISTRATION OF A CHARGE / CHARGE CODE 021589960002 | |
CH01 | Director's details changed for Mr Manish Khandelwal on 2019-03-04 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR PIRET SELL | |
AP01 | DIRECTOR APPOINTED MISS JANE HILL | |
RES01 | ADOPT ARTICLES 06/02/19 | |
CS01 | CONFIRMATION STATEMENT MADE ON 31/12/18, WITH UPDATES | |
PSC02 | Notification of Ai Sirona (Luxembourg) Acquisition S.A.R.L. as a person with significant control on 2018-09-30 | |
PSC07 | CESSATION OF AVENTIS PHARMA LIMITED AS A PERSON OF SIGNIFICANT CONTROL | |
AD03 | Registers moved to registered inspection location of Office 136-152 Austen House Station View Units a-J Guildford Surrey GU1 4AR | |
AD02 | Register inspection address changed to Office 136-152 Austen House Station View Units a-J Guildford Surrey GU1 4AR | |
AA | ACCOUNTS FOR DORMANT COMPANY MADE UP TO 31/12/17 | |
RES10 | Resolutions passed:
| |
SH01 | 26/09/18 STATEMENT OF CAPITAL GBP 2 | |
AP01 | DIRECTOR APPOINTED MR MANISH KHANDELWAL | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR FRANCOIS-XAVIER DUHALDE | |
RES15 | CHANGE OF COMPANY NAME 05/07/18 | |
CERTNM | COMPANY NAME CHANGED WINTHROP PHARMACEUTICALS UK LIMITED CERTIFICATE ISSUED ON 05/07/18 | |
DISS40 | Compulsory strike-off action has been discontinued | |
GAZ1 | FIRST GAZETTE notice for compulsory strike-off | |
CS01 | CONFIRMATION STATEMENT MADE ON 31/12/17, WITH NO UPDATES | |
AA | ACCOUNTS FOR DORMANT COMPANY MADE UP TO 31/12/16 | |
AP01 | DIRECTOR APPOINTED MR HUGO RUPERT ALEXANDER FRY | |
LATEST SOC | 12/01/17 STATEMENT OF CAPITAL;GBP 1 | |
CS01 | CONFIRMATION STATEMENT MADE ON 31/12/16, WITH UPDATES | |
AA | ACCOUNTS FOR DORMANT COMPANY MADE UP TO 31/12/15 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR TARJA JOHANNA STENVALL | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR ANDREW MICHAEL JAMES PROSSER | |
AP01 | DIRECTOR APPOINTED MR FRANCOIS-XAVIER DUHALDE | |
LATEST SOC | 19/01/16 STATEMENT OF CAPITAL;GBP 1 | |
AR01 | 31/12/15 ANNUAL RETURN FULL LIST | |
AA | ACCOUNTS FOR DORMANT COMPANY MADE UP TO 31/12/14 | |
LATEST SOC | 12/01/15 STATEMENT OF CAPITAL;GBP 1 | |
AR01 | 31/12/14 FULL LIST | |
AA | FULL ACCOUNTS MADE UP TO 31/12/13 | |
AP01 | DIRECTOR APPOINTED MRS TARJA JOHANNA STENVALL | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR STEPHEN OLDFIELD | |
LATEST SOC | 29/01/14 STATEMENT OF CAPITAL;GBP 1 | |
AR01 | 31/12/13 FULL LIST | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / MR STEPHEN PHILIP OLDFIELD / 31/12/2013 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / MR ANDREW MICHAEL JAMES PROSSER / 31/12/2013 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/12 | |
AR01 | 31/12/12 FULL LIST | |
SH20 | STATEMENT BY DIRECTORS | |
SH19 | 19/12/12 STATEMENT OF CAPITAL GBP 1 | |
RES06 | REDUCE ISSUED CAPITAL 13/12/2012 | |
CAP-SS | SOLVENCY STATEMENT DATED 13/12/12 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/11 | |
AR01 | 31/12/11 FULL LIST | |
SH19 | 11/01/12 STATEMENT OF CAPITAL GBP 63500 | |
SH20 | STATEMENT BY DIRECTORS | |
CAP-SS | SOLVENCY STATEMENT DATED 22/12/11 | |
RES13 | SHARE PREMIUM REDUCED TO NIL 22/12/2011 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / ANDREW MICHAEL JAMES PROSSER / 20/10/2011 | |
MISC | SECTION 519 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/10 | |
AR01 | 05/03/11 FULL LIST | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR MICHAEL MCCLELLAN | |
AA | FULL ACCOUNTS MADE UP TO 31/12/09 | |
AP01 | DIRECTOR APPOINTED ANDREW MICHAEL JAMES PROSSER | |
AP01 | DIRECTOR APPOINTED STEPHEN PHILIP OLDFIELD | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / MICHAEL JAMES MCCLELLAN / 12/05/2010 | |
RES01 | ADOPT ARTICLES 12/05/2010 | |
CC04 | STATEMENT OF COMPANY'S OBJECTS | |
TM02 | APPOINTMENT TERMINATED, SECRETARY MICHAEL MCCLELLAN | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR NIGEL BROOKSBY | |
AR01 | 05/03/10 FULL LIST | |
AA | FULL ACCOUNTS MADE UP TO 31/12/08 | |
288c | DIRECTOR'S CHANGE OF PARTICULARS / NIGEL BROOKSBY / 03/06/2009 | |
288c | DIRECTOR AND SECRETARY'S CHANGE OF PARTICULARS / MICHAEL MCCLELLAN / 03/06/2009 | |
288b | APPOINTMENT TERMINATED DIRECTOR ETIENNE JACOB | |
363a | RETURN MADE UP TO 05/03/09; FULL LIST OF MEMBERS | |
AA | FULL ACCOUNTS MADE UP TO 31/12/07 | |
288b | APPOINTMENT TERMINATE, DIRECTOR BLAKE ALEXANDER DARK LOGGED FORM | |
363s | RETURN MADE UP TO 05/03/08; FULL LIST OF MEMBERS | |
288a | NEW SECRETARY APPOINTED | |
288b | SECRETARY RESIGNED | |
288b | DIRECTOR RESIGNED | |
288a | NEW DIRECTOR APPOINTED | |
288b | DIRECTOR RESIGNED | |
AA | FULL ACCOUNTS MADE UP TO 31/12/06 | |
363s | RETURN MADE UP TO 05/03/07; FULL LIST OF MEMBERS | |
AA | FULL ACCOUNTS MADE UP TO 31/12/05 | |
363s | RETURN MADE UP TO 05/03/06; FULL LIST OF MEMBERS | |
AA | FULL ACCOUNTS MADE UP TO 31/12/04 | |
244 | DELIVERY EXT'D 3 MTH 31/12/04 | |
363s | RETURN MADE UP TO 05/03/05; FULL LIST OF MEMBERS | |
288b | DIRECTOR RESIGNED | |
288a | NEW DIRECTOR APPOINTED | |
288b | DIRECTOR RESIGNED | |
288a | NEW DIRECTOR APPOINTED | |
CERTNM | COMPANY NAME CHANGED STERWIN MEDICINES LIMITED CERTIFICATE ISSUED ON 30/12/04 | |
288a | NEW DIRECTOR APPOINTED | |
288a | NEW DIRECTOR APPOINTED | |
288b | DIRECTOR RESIGNED | |
AA | FULL ACCOUNTS MADE UP TO 31/12/03 | |
288c | DIRECTOR'S PARTICULARS CHANGED |
Total # Mortgages/Charges | 2 |
---|---|
Mortgages/Charges outstanding | 2 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 0 |
The top companies supplying to UK government with the same SIC code (46460 - Wholesale of pharmaceutical goods) as ZENTIVA PHARMA UK LIMITED are:
Origin | Destination | Date | Import Code | Imported Goods classification description |
---|---|---|---|---|
30044900 | ||||
30044900 | ||||
30049000 | Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins | |||
30049000 | Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins | |||
30044900 | ||||
30044900 | ||||
30049000 | Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins | |||
30049000 | Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins | |||
30044900 | ||||
30044900 | ||||
30049000 | Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins | |||
30049000 | Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins |
For goods imported into the United Kingdom, only imports originating from outside the EU are shown
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |